News & views

UCL has once again been recognised as one of the UK's leading universities for 'knowledge exchange'.

From surgery to data centres, UCL Ventures’ spinouts are using AI to transform lives

Investment will accelerate the translation of world-leading ophthalmology research into clinical practice

UCL spinout’s acoustic emission sensing and AI technology could reduce battery manufacturing time by 30%

First patient trial uses soundwaves to reach deep brain structures without surgery or implants.

Dr Anne Lane has spoken about university commercialisation as CEO of UCL's expert commercialisation partner

Spinout Trace Neuroscience reaches a major milestone

A UCL Ventures spinout is opening up the World Cup experience to more people, using accessible technology.

Academic-turned-founder Dr. Martin Pule spoke about the realities and rewards taking cancer therapies to market at I-O Converse.

A new identity for the expert commercialisation partner of UCL.

A CAR T-cell therapy developed by a UCL Ventures' spinout has shown early results for people with severe, treatment-resistant lupus.

UCL research into ‘aerogel’ technology powers the first breakthrough in 30 years.